Boeing ( BA) upgraded at Jesup & Lamont from Hold to Buy. $63 price target. Stock is trading at an attractive risk/reward ratio.

Boeing ( BA) upgraded at Barclays to Overweight from Equal Weight. Price target jumped to $65 from $57. 2009 and 2010 EPS estimates lowered to $1.20 and $4.40, respectively.

Beckman Coulter ( BEC) upgraded at JP Morgan. Rating raised to Overweight from Neutral. Maintains $75 price target and 2009 EPS estimates of $3.82.

Boston Scientific ( BSX) downgraded at Baird from Outperform to Neutral. $10 price target. Company is reliant on slow-growth markets.

Bucyrus ( BUCY) target, estimate raised at Barclays. BUCY price target surged to $73 from $64. 2010 EPS estimate increased to $3.55 from $2.90. Maintain Overweight rating.

Bucyrus ( BUCY) rated new Outperform at Morgan Stanley. $71 price target. Terex purchase was a positive and should materially add to earnings.

Chesapeake Energy ( CHK) downgraded at Goldman from Buy to Neutral. Valuation call, despite the company's attractive resource upside.

Con-way ( CNW) upgraded at BofA/Merrill to Buy from Neutral. Price target set at $45. YRC's market share losses makes valuation increasingly attractive for CNW.

Calpine ( CPN) upgraded at Jefferies from Underperform to Hold. $11.50 price target. Company has reduced exposure to gas and trades at an attractive valuation.

Dynegy ( DYN) upgraded at Jefferies from Underperform to Hold. Valuation call, based on a $1.80 price target.

Brinker ( EAT) downgraded at UBS from Buy to Neutral. $16 price target. Estimates also lowered, as sales trends appear to have deteriorated.

If you liked this article you might like

Fed Pares $4.5 Trillion Balance Sheet But Easy-Money Era Isn't Over

Bank Stocks Move Higher as Fed Decides to Start Unwinding Balance Sheet

Bank Stocks Move Higher Ahead of Federal Reserve Meeting

All Eyes on the Godfather of Central Banking as Fed Has Huge Meeting This Week

The Stock Market Stinks and the Stench Is Going to Get Much Worse Soon